KPV (Lysine-Proline-Valine) is a naturally occurring tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH), widely studied for its potent anti-inflammatory, immunomodulatory, and gut-protective properties, making it a promising compound in research related to inflammatory conditions, skin health, and gastrointestinal support; KPV works by modulating key inflammatory pathways, including the inhibition of pro-inflammatory cytokines such as TNF-alpha and interleukins, while also helping regulate immune responses without broadly suppressing immune function, which has driven interest in its potential applications for conditions like inflammatory bowel disease, colitis, and skin disorders; research suggests that KPV may help support intestinal barrier integrity, reduce inflammation in the gut, and promote healing of damaged tissues, while topical and experimental applications have shown benefits in calming irritated skin and supporting recovery from inflammatory skin conditions; unlike larger peptide hormones, KPV retains targeted biological activity in a smaller, more stable structure, contributing to its growing popularity in peptide research and advanced wellness discussions; as interest in targeted anti-inflammatory peptides continues to rise, KPV is increasingly recognized for its ability to address inflammation at a cellular level while supporting overall tissue health and immune balance.